4D Molecular Therapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

18.12.24	What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics (Benzinga)
19.09.24	4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate (Benzinga)
09.09.24	The Latest Analyst Ratings For 4D Molecular Therapeutics (Benzinga)
18.07.24	Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights (Benzinga)
17.07.24	4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate (Benzinga)
26.06.24	Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts (Benzinga)
06.06.24	Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released (Benzinga)
28.03.24	4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease (Benzinga)
01.03.24	4D Molecular Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) (Benzinga)
07.02.24	Why 4D Molecular Therapeutics (FDMT) Stock Is Diving (Benzinga)
07.02.24	What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics (Benzinga)
05.02.24	Why Is Eye Disease-Focused 4D Molecular Therapeutics Stock Shooting Higher Today? (Benzinga)
05.02.24	Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket (Benzinga)
23.01.24	4DMT Secures FDA RPDD For Aerosolized 4D-710 (RTTNews)
11.07.23	Astellas and 4D Molecular Therapeutics (4DMT) Enter into License Agreement to Use 4DMT's Proprietary Intravitreal R100 Vector for Rare Ophthalmic Targets (PR Newswire)
12.10.21	2 Catalysts That Could Move The Share Price Of 4D Molecular Therapeutics In Q4 (RTTNews)
06.10.21	4D Molecular Plans Initiation Of Phase 1/2 Trials With 4D-150 In Wet AMD, 4D-710 In Cystic Fibrosis (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.50	-0.16 %	K V
Kuehne+Nagel Int	201.70	-0.30 %	K V
Nestle	73.86	-0.32 %	K V
Swiss Life Hldg	685.40	-0.52 %	K V
Novartis	87.34	-0.80 %	K V
CieFinRichemont	133.80	-2.37 %	K V
Logitech Intl	72.52	-3.07 %	K V
UBS Group	26.87	-3.41 %	K V
ABB	49.15	-4.60 %	K V
Part Grp Hldg	1’209.50	-4.88 %	K V